Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PHRM 845 final > Antidepressants > Flashcards

Antidepressants Flashcards

1
Q

Drug Induces Depression

A

Antihypertensive and cardiovascular
Sedative hypnotics
anti-inflammatory and analgesics
steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk of recurrence of depression

A

1 episode: 50-6-%
2 episodes: 70%
3 episodes: 90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Biogenic amine hypothesis of depression

A

Reserpine causes depression by depleting NE and 5HT from vesicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Neuroendocrine hypothesis of depression

A

overactivity of hypothalamic-pituitary adrenal axis causes an elevation of cortisol releasing factor which increases depression symptoms (causes insomnia, anxiety, decreased appetite and libido)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Neurotrophic hypothesis of depression

A

Brain-derived neurotrophic factor (BDNF) is decreased when experiencing pain and stress (so we want to increase BDNF levels to treat depression Sx)
BDNF has ‘antidepressant’ activity in animals
BDNF is important for neuronal connections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Integration of hypotheses of depression

A
  • HPA and steroid abnormalities regulate BDNF levels
  • Hippocampal glucocorticoid receptors are activated by cortisol during stress (decreasing BDNF)
  • chronic activation of monoamine receptors increase BDNF signaling (through neurotrophic pathway)
  • chronic activation of monoamine receptors leads to down regulation of HPA axis (through neuroendocrine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Delayed therapeutic response of antidepressants

A

SSRI will cause an immediate increase of 5HT in brain, but clinically the effect will not affect depression symptoms for days or weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mechanism of MAOIs

A
  • NE and 5HT are normally degraded by monoamine oxidase
  • increased amount of NE and 5HT packaged in vesicles because inhibiting monoamine oxidase
  • causes depolarization and release, so we have more monoamines to activate pre and post synaptic receptors
  • MAO -A breaks down 5HT & NE
  • MAO-B breaks down dopamine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MAO inhibitors (drugs)

A

Non-selective: (irreversible)
- Phenelzine (nardil)
- Tranylcypromine (parnate)
MAO-B selective: (reversible)
- selegiline
MAO-A selective: (reversible)
- moclobemide (manerix)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MAOIs pearls

A
  • Severe side effects: headache, drowsiness, dry mouth, weight gain, orthostatic hypotension, sexual dysfunction
  • hypertensive crisis
  • interactions with: TCAs, SSRIs, L-DOPA, cold preparations, diet pills
  • avoid foods with Tyramine (ex. cheese, sour cream, liver, sausage, pepperoni, avocados, bananas, figs, soy sauce, ginseng)
  • avoid St. John’s wort with MAOIs bc of its MAOI activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Tricyclic antidepressants

A

Intication: depression, panic disorder, chronic pain, enuresis
overdose/toxicity: depressed patients more likely to be suicidal (bc have enough energy from drugs before therapy ‘kicks in’ so often self harm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tertiary Amines (TCA)

A
  • 1st class of TCAs
  • inhibit NE and 5HT reuptake via NET and SERT
  • antihistamine, antimuscarinic, antiadrenergic activity
  • SE: sedation, autonomic SE, weight gain

Drugs:
- imipramine (tofranil) - metabolized to desipramine - for enuresis and ADHD
- amitriptyline (elavil) - metabolized to nortriptyline
- clomipramine - used of OCD
- doxepin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Secondary Amines (TCA)

A
  • 2nd class of TCAs
  • better NET inhibitors than SERT
  • SE: less sedation, anticholinergic, autonomic, weight gain, cardiovasular effects than tertiary amines

Drugs:
- desipramine (norpramin)
- nortriptyline (pamelor)
- maprotiline (ludiomil)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SSRI mechanism

A
  • Seretonin transporters pumps are blocked, which increases the amount of 5HT in the synapse, 5HT stays in the synapse longer and remains active longer
  • uses: depression, alcoholism, OCD, enuresis, PTSD, eating disorders, social phobias, panic, PMDD, GAD
  • SE: N/V, headache, sexual dysfunction, anxiety, insomnia, tremor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

SSRI drugs

A
  • fluoxetine (prozac)
  • fluvoxamine (luvox)
  • paroxetine (paxil)
  • sertraline (zoloft)
  • citalopram (celexa)
  • escitalopram oxalate (lexapro)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

SSRI discontinuation syndrome

A

“brain zaps”. dizziness, sweating, nausea, insomnia, tremor, confusion, vertigo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Serotonin syndrome

A

when given with MAOIs, TCAs
- also metoclopramide, tramadol, triptans, st john’s wort
- symptoms: hyperthermia, muscle rigidity, restlessness, myoclonus, sweating, shivering, seizures
- treatment: discontinuation of medication and management of symptoms, serotonin antagonists, BZDs to control myoclonus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

SSRI + 5HT1A partial agonists

A

vilazodone (viibryd)
-reduced sexual SE vs pure SSRIs
-similat 5HT1A action to aripiprazole and buspirone
votrioxetine (brintellex)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Tetracyclic and Unicyclic

A
  • maprotiline (ludiomil) - NET inhibitor
  • amoxapine (ascendin) - NET inhibitor, D2 antagonist
  • mirtazapine (remeron) - a2 antagonist, 5HT2 & 5HT3 antagonist, H1 antagonish
  • bupropion (wellbutrin) - DAT inhibitor, NET & SERT inhibitor, also treats GAD, Zyban for smoking cessation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

SNRIs

A

Venlafaxine (effexor)
- NET & SERT inhibitors
- treats GAD and panic disorder
Desvenlafaxine (pristiq)
- NET & SERT inhibitor
- treatment of vasomotor symptoms associated with menopause
duloxetine (cymbalta)
- NET & SERT inhibitor
- treats GAD and peripheral neuropathy
milnacipran (ixel)
- NET & SERT inhibitor
- approved for fibromayalgia
levomilnacipran (fetzima)
-active enantiomer of milnacipran
-NET & SERT inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Norepinephrine selective reuptake inhibitors

A

reboxetine (vestra, edornax)
-possibly less side effects than prozac
atomoxetine (straterra)
-used for ADHD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Serotonin-Norepinephrine-Dopamine Reuptake Inhibitors (SNDRIs)

A
  • “triple blockers”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Rapidly acting antidepressants: NMDA Antagonists

A
  • ketamine- subanaesthetic doses
  • scopolamine (muscarinic & NMDA antagonist)
  • Lanicemine - “low trapping”
24
Q

clinically used NMDA antagonists

A

ketamine
eskatamne (spravato) - in conjunction with oral antidepressant
- CNS effects: depression, drug interactions
- intranasal based dosing

25
Q

Postpartum depression (PPD)

A
  • SSRIS (fluoxetine and paroxetine) and venlafaxine
  • Brexanolone - allopregnanolone levels increase in pregnancy and return to normal postpartum. Brexanolone resensitizes GABA-A receptors which makes membrane potential back to normal so decreases PPD.
26
Q

DSM 5 Diagnostic critetia of depression

A
  • at least one of the symptoms must be depressed mood or loss of interest or pleasure in doing things
    S - sleep (insomnia/hypersomnia)
    I - interest decreased
    G - guit/worthlessness
    E - energy loss/fatigue
    C - concentration difficulties
    A - appetite change (increase or decrease)
    P - psychomotor agitation/retardation
    S - suicidal ideation
27
Q

citalopram (celexa)

A
  • SSRI
  • dose-dependent QTc prolongation
  • substrate of 2C19 and 3A4
28
Q

escitalopram (lexapro)

A
  • SSRI
  • pure S-enantiomer of citalopram
  • substrate of 2C19
29
Q

fluoxetine (prozac)

A
  • SSRI
  • long half life (96-144 hrs)
  • activating potential
  • 2D6 inhibitor, 3A4 inhibitor
30
Q

fluvoxamine (luvox)

A
  • SSRI
  • inhibitor of 1A2, 2C19
  • indicated for OCD treatment
31
Q

paroxetine

A
  • SSRI
  • MUST taper due to anticholinergic effects
  • weight gain, sedation
  • septal wall defect risk to the fetus
  • inhibitor 2D6, 2B6
32
Q

sertraline (zoloft)

A
  • SSRI
  • more GI upset than other antidepressants
  • inhibitor 2C19, 2D6, 3A4
33
Q

SSRI - adverse effects/key points

A
  • onset of action is 1-2 weeks
  • 4-6 weeks until full dose response observed
  • increased bleed risk (platelet inhibition)
  • weight gain (paroxetine)
  • hyponatremia especially in elderly
  • weight loss (fluoxetine)
  • sexual dysfunction
34
Q

desvenlafaxine (pristiq)

A
  • SNRI
  • active metabolite of venlafaxine
  • dose-limiting SE: nausea
  • no major CYP interactions
35
Q

duloxetine (cymbalta)

A
  • SNRI – go to SNRI
  • slow titration of divided dosing to help with nausea
  • FDA warning for hepatotoxicity
  • inhibitor 2D6
35
Q

levomilnacipran (fetzima)

A
  • SNRI
  • must adjust in renal impairment or strong 3A4 inhibitors
  • 3A4 substrate
35
Q

milnacipran (savella)

A
  • SNRI
  • indicated for fibromyalgia
  • renal dosage adjustments
36
Q

SNRI adverse effects/key points

A
  • onset is 1-2 weeks but clinical benefit 4-6
  • useful in pain syndrome, musculoskeletal pain, fibromyalgia, and neuropathic pain
  • blood pressure elevation
  • nausea
  • duloxetine: obtain LFTs at baseline and when symptomatic or every 6 months
36
Q

venlafaxine (effexor)

A
  • SNRI
  • must be >150mg per day to have NE effects
  • 2D6 inhibitor at higher doses
  • substrate 2D6 and 3A4
36
Q

TCAs

A
  • blockade of reuptake transporter (DAT, SERT, NET) which inhibits the reuptake of serotonin, NE, and DA
  • amitriptyline (elavil) - tertiary amine
    – used low doses for neuropathi pain
36
Q

MAO inhibitors

A
  • not commonly used
  • old antidepressants but super effective
  • must have 2 weeks washout period before switching antidepressants
  • all require tyramine diet except selegiline patch
  • caution due to hypertensive crisis and serotonin syndrome
36
Q

selegiline patch

A
  • selective MAO-B inhibitor at low doses
  • tyramine diet NOT required with this patch
36
Q

TCAs adverse effects/key points

A
  • most often used for neuropathic syndromes than depression – amitriptyline or nortriptyline
  • CNS: sedation, reduced seizure threshold, confusion
  • anticholinergic: blurred vision, urinary retention, constipation
  • cardiovascular: orthostatic hypotension, tachycardia
  • other: weight gain, sexual dysfunction
36
Q

mirtazapine (remeron)

A
  • presynaptic a2 blockade as well as 5HT2, 5HT3, and H2 blockade (can be combined with SSRI/SNRI)
  • sedation and increased appetite occur with doses less than 15mg/day
  • agranulocytosis, increased cholesterol
  • can be used with SSRI/SNRI
36
Q

buproprion (wellbutrin)

A
  • dopamine and norepinephrine reuptake inhibitor
  • stimulating - insomnia, appetite suppression
  • XL dosing for depression
  • 2D6 inhibitor
  • CI in active seizure
37
Q

trazadone (desyrel)

A
  • SSRI but also impacts 5HT1 and 1
  • high dose needed for depression
  • Drug interactions: trazadone –3A4, 2D6
  • SE: orthostatic hypotension, risk of priapism
38
Q

vilazodone (viibryd)

A
  • SSRI with 5HT1A agonism (helps proviod anxiolytic effects)
  • do not use in combo with SSRI/SNRI
  • take with food bc nausea
  • bioavailability increases with food
  • 3A4 substrate
39
Q

vortioxetine (trintellix)

A
  • SSRI + 5HT1A agonist + 5HT3 antagonist
  • do not use in combo with SSRI/SNRI
  • possibly less sexual dysfunction
  • 2D6 substrate
  • nausea
40
Q

Serotonin syndrome treatment

A
  • stop the offending agent + supportive care
  • potentially could use serotonin blockers (cyproheptadine)
41
Q

Antidepressant withdrawal syndrome

A
  • common with ALL antidepressants EXCEPT fluoxetine
  • not life threatening but extremely uncomfortable (so we should slowly taper when discontinuing)
  • antidepressants with anticholinergic activity should be tapered no matter what
42
Q

augmentation agents (for depression)

A

antipsychotics
lithium
anticonvulsants
pindolol
triiodothryonine
benzodiazepines
buspirone
atomoxetine

43
Q

atypical antipsychotics (add on for depression)

A
  • dosing is lower for depression than other states
  • FDA approved: aripiprazole, brexpiprazole, cariprazine, quetipine
44
Q

Antidepressants for Post-partum

A
  • allosteric modulators of alloprenanolone
  • brexanolone - iv only
  • zuranolone - oral dose
45
Q

Antidepressants for treatment resistant depression

A

Esketamine nasal spray - NMDA receptor antagonist

46
Q

overall key counseling points for depression

A
  • may take 2-4 weeks to see benefit
  • abrupt discontinuation may lead to antidepressant withdrawal syndrome
  • possible increase in suicidal thinking in first few weeks of therapy
47
Q
A

PHRM 845 final (4 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions